Cyprus start-up mar­kets Down’s syn­drome test

Financial Mirror (Cyprus) - - FRONT PAGE -

A rev­o­lu­tion­ary non-in­va­sive pre­na­tal di­ag­nos­tic test for Down’s Syn­drome is now avail­able from NIPD Ge­net­ics Ltd., a start-up com­pany cre­ated by the Cyprus In­sti­tute of Neu­rol­ogy and Ge­net­ics in 2010.

The test for Down’s Syn­drome, or tri­somy 21, a ge­netic dis­or­der caused by the pres­ence of all or part of a third copy of chro­mo­some 21, was dis­cov­ered in 2011 by re­searchers un­der Pro­fes­sor Philip­pos Pat­salis, then Gen­eral Direc­tor of the In­sti­tute of Neu­rol­ogy and Ge­net­ics and presently Min­is­ter of Health.

The Ve­rac­ity Test, as it is called, is an in­no­va­tive pre­na­tal test that can pro­vide all preg­nant women, at very low cost, with high ac­cu­racy and re­li­a­bil­ity, but also with­out any risk to the fe­tus, a non­in­va­sive pre­na­tal screen­ing for the syn­drome, tri­somy 18, tri­somy 13, mono­somy X and the sex of the fe­tus.

The non-in­va­sive pre­na­tal test Ve­rac­ity can be pro­vided to ev­ery preg­nant woman, in Cyprus and abroad, who wants to know early dur­ing her preg­nancy if her child has Down’s syn­drome or other ge­netic dis­or­ders.

Its great­est ad­van­tage is that the test does not put the preg­nancy or the life of the fe­tus at any risk.

The test is 100% safe for the health of the mother and for the life of the fe­tus, un­like in­va­sive meth­ods of pre­na­tal di­ag­no­sis, such as am­nio­cen­te­sis and CVS, which can cause mis­car­riage in 1-2% of the cases.

The Ve­rac­ity test can be used any time af­ter the tenth week of preg­nancy. The re­sults of any blood test (from all over the world) will be an­a­lysed in the com­pany’s lab­o­ra­to­ries in Ni­cosia and sent back to the doc­tor.

NIPD Ge­net­ics put the test on the mar­ket this week and ex­pressed be­lief that it will soon be adopted around the world as part of the preg­nancy care.

The com­pany is a pri­vately held start-up com­pany aim­ing to de­sign, de­velop and man­u­fac­ture non-in­va­sive in vitro di­ag­nos­tic tests for the di­ag­no­sis of ge­netic dis­eases and syn­dromes dur­ing the early stages of preg­nancy.

Newspapers in English

Newspapers from Cyprus

© PressReader. All rights reserved.